We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+15.32%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$9.31B
AUM Growth
+$1.38B
Cap. Flow
+$1.01B
Cap. Flow %
10.84%
Top 10 Hldgs %
57.26%
Holding
226
New
90
Increased
25
Reduced
49
Closed
45

Sector Composition

Rank Sector Weight
1 Healthcare 15.64%
2 Technology 8.71%
3 Communication Services 5.59%
4 Industrials 3.72%
5 Materials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.89B 20.29%
6,445,300
+2,745,300
+74% +$791M
APC
2
DELISTED
Anadarko Petroleum
APC
$619M 6.66%
+8,779,500
New +$589M
AGN
3
DELISTED
Allergan plc
AGN
$599M 6.43%
3,576,000
+3,554,000
+16,155% +$492M
CELG
4
DELISTED
Celgene Corp
CELG
$532M 5.72%
5,754,000
-4,031,000
-41% -$383M
RHT
5
DELISTED
Red Hat Inc
RHT
$457M 4.91%
2,434,507
+669,507
+38% +$124M
CELG
6
PUT
DELISTED
Celgene Corp
CELG
$292M 3.13%
3,155,000
-8,531,200
-73% -$810M
ZAYO
7
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$268M 2.88%
8,150,000
+7,250,000
+806% +$231M
CY
8
DELISTED
Cypress Semiconductor
CY
$227M 2.44%
+10,220,000
New +$185M
TRQ
9
DELISTED
Turquoise Hill Resources Ltd
TRQ
$226M 2.42%
18,194,121
-592,000
-3% -$8.19M
MLNX
10
DELISTED
Mellanox Technologies, Ltd.
MLNX
$220M 2.36%
1,986,448
+416,448
+27% +$48M
NXPI icon
11
NXP Semiconductors
NXPI
$68B
$219M 2.35%
2,241,000
-181,000
-7% -$17.5M
NXPI icon
12
CALL
NXP Semiconductors
NXPI
$68B
$207M 2.23%
2,125,000
+170,000
+9% +$16.5M
CI icon
13
PUT
Cigna
CI
$76.6B
$185M 1.99%
1,175,000
-205,000
-15% -$32.1M
MLNX
14
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
$166M 1.78%
1,500,000
+1,460,000
+3,650% +$168M
OXY icon
15
CALL
Occidental Petroleum
OXY
$57B
$157M 1.69%
+3,130,000
New +$176M
ARRY
16
DELISTED
Array Biopharma Inc
ARRY
$128M 1.38%
+2,765,000
New +$77.6M
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
$114M 1.23%
400,900
-674,100
-63% -$186M
ESPR
18
DELISTED
Esperion Therapeutics
ESPR
$113M 1.22%
2,435,500
-41,000
-2% -$1.93M
QQQ icon
19
PUT
Invesco QQQ Trust
QQQ
$455B
$112M 1.2%
+599,600
New +$110M
WCG
20
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
$111M 1.19%
390,000
+210,000
+117% +$57.9M
PCG icon
21
PG&E
PCG
$47.8B
$105M 1.13%
4,573,200
-1,166,800
-20% -$23.4M
WP
22
DELISTED
Worldpay, Inc.
WP
$102M 1.09%
828,543
+608,543
+277% +$72.2M
DATA
23
DELISTED
Tableau Software, Inc.
DATA
$100M 1.08%
+603,416
New +$79.3M
BA icon
24
Boeing
BA
$165B
$94.1M 1.01%
258,400
+224,400
+660% +$81.8M
CZR
25
DELISTED
Caesars Entertainment Corporation
CZR
$89.8M 0.97%
7,600,600
+7,250,600
+2,072% +$68.7M

Similar funds

Pentwater Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Pentwater Capital Management held 226 positions worth $9.31B, up 17% from $7.93B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Pentwater Capital Management deployed $1.01B of net new capital in Q2 2019, opening 90 new positions and adding to 25 existing holdings. Its largest new stake was Anadarko Petroleum: 8,779,500 shares worth $619M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Celgene Corp, an estimated $383M trimmed.

  • Pentwater Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 8,779,500 shares worth $619M.
  • Pentwater Capital Management added most to Allergan plc in Q2 2019, an estimated $492M increase.
  • Pentwater Capital Management's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $383M.
  • Pentwater Capital Management fully exited Walt Disney in Q2 2019, selling an estimated $196M.
  • Pentwater Capital Management's ten largest holdings make up 57% of its $9.31B portfolio in Q2 2019.
  • Pentwater Capital Management opened 90 new positions and closed 45 in Q2 2019.
  • Pentwater Capital Management's portfolio value rose 17% quarter-over-quarter to $9.31B.

Based on Pentwater Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.